company
as of 2026-07-01University of Cologne
at a glance
16 trials sponsored · 20 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
20 assets
AmisulprideCannabidiolOlanzapineQuetiapineRisperidoneCognitive Behavioral Therapy (CBT)IPPI (Integrated Preventive Psychological Intervention)Integrated Social Cognitive and Behavioral Skills TherapyN-acetylcysteineNeurocognitive Remediation TherapyOxcarbazepinePSM (Psychological stress management)PlacebSkills trainig for patients with dual diagnosisSupportive Counselling (SC)Supportive managementantipsychotics vs. Lorazepam (Drugs)maintained antipsychotic treatment vs. stepwise drug discontinuationmodified cognitive behavioural therapy (mCBT)regular treatment
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
drugsmall molecule
Cannabidiol
drugsmall molecule
Olanzapine
drugsmall molecule
Quetiapine
drugsmall molecule
Risperidone
drugsmall molecule
Cognitive Behavioral Therapy (CBT)
drugBEHAVIORAL
drug